The Devil in the Details - Chapter Two

In the first of this five-part season we trace Katharine’s early years as she picks up European languages, her early scientific education at a progressive New York school for girls and then Bryn Mawr, a women’s college. She seems destined to end up working at the General Electric ...  Show more

Introducing Layers of Brilliance, a five-part season that brings to life the story of a woman whose discoveries in materials science quietly shape our everyday world – but whose legacy was long eclipsed by the famous scientist she worked with.In 1918, at just twenty years old, Ka ...  Show more

ALS is a fatal neurological disease that kills motor neurons. Even though it was first described more than 150 years ago, there is no cure, and the few drugs available only dampen the symptoms or slow the progression by a few months. In recent years new drugs have emerged. How ...

In 1960, FDA scientist Frances Oldham Kelsey is tasked with approving an application for a mild sedative to be sold in America. The drug is popular across Europe and is touted to be free of side effects, so this should be a routine job. But something doesn't sit right with France ...  Show more

Benjamin Y. Fong is author of the new book Quick Fixes: Drugs in America from Prohibition to the 21st Century Binge, which was just released in July, 2023 by Verso Books. Ben is an honors faculty fellow and associate director of the Center for Work & Democracy at Arizona State Un ...  Show more

Ketamine was designed as an anaesthetic but its use as a recreational drug is growing fast, particularly among young people. In the UK, it’s doubled in less than ten years but it can cause serious side effects. The supply chain for the drug starts with pharmaceutical manufacturer ...  Show more